Tevogen Inc. Convertible Notes Payable, Current
Tevogen Inc. (TVGN) had Convertible Notes Payable, Current of $80.71 million as of 2023-12-31, per its 10-K filed 2025-04-02.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2025-04-02
- 2023-12-31: Convertible Notes Payable, Current $80.71M; Convertible Notes Payable, Current as first filed $1.63M.
- 2023-09-30: Convertible Notes Payable, Current $625.69K.
- 2023-06-30: Convertible Notes Payable, Current $625.69K.
| Period end | Convertible Notes Payable, Current | Convertible Notes Payable, Current as first filed |
|---|---|---|
| 2023-12-31 | $80.71M 10-K · filed 2025-04-02 | $1.63M 10-K · filed 2024-04-29 |
| 2023-09-30 | $625.69K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $625.69K 10-Q · filed 2023-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B |